FBXW7 and prostate carcinoma: Depletion of FBXW7 abrogated inhibition of cell proliferation caused by upregulation of FER1L4 in prostate cancer cells, indicating that FER1L4 exerted antitumor activities via miR-92a-3p/FBXW7 axis (94).